Related Experiment Videos
[Myasthenic syndrome induced by lithium].
T Ronzière1, P Auzou, C Ozsancak
1Service de Neurologie, CHU Pontchaillou, Rennes.
Presse Medicale (Paris, France : 1983)
|June 30, 2000
Summary
Lithium treatment can cause neuromuscular junction dysfunction, leading to myasthenia syndrome. This condition improved after discontinuing lithium, highlighting a potential side effect of this common medication.
Area of Science:
- Neurology
- Pharmacology
- Neuroscience
Background:
- Lithium salts are frequently prescribed for bipolar disorder.
- Neuromuscular junction dysfunction is a potential adverse effect of lithium therapy.
Observation:
- A patient with bipolar psychosis developed significant fatigue.
- The fatigue was indicative of a myasthenia syndrome.
- Symptoms resolved after lithium cessation.
Findings:
- Lithium-induced myasthenia syndrome is a recognized, albeit rare, complication.
- Four cases of neuromuscular junction disorders linked to lithium treatment were identified in the literature.
- Lithium can either induce myasthenia or unmask pre-existing myasthenia.
Implications:
- Clinicians must consider lithium-induced neuromuscular junction disorders in patients presenting with fatigue.
- Awareness of this potential side effect is crucial for accurate diagnosis and management.
- Understanding the pathophysiological mechanisms is important for patient care.